Lorraine McLoughlin

Title: Lorraine McLoughlin: Innovator in Gastrin Hormone Immunoassays

Introduction

Lorraine McLoughlin is a notable inventor based in Cambridgeshire, GB. She has made significant contributions to the field of immunoassays, particularly in the detection and quantitation of gastrin hormones. With a total of two patents to her name, her work has implications for medical diagnostics and treatment.

Latest Patents

McLoughlin's latest patents focus on gastrin hormone immunoassays. These inventions provide assay methods for the detection and quantitation of gastrin hormones, including both total and free gastrin hormone in a sample. The ELISA-type heterogeneous phase assays are suitable for use with biological fluid samples such as blood, plasma, or other bodily fluids of mammals, particularly humans. The methods offer precise assays for the amounts of free and total G17 and G34, as well as the amounts of free and total Gly-extended G17 and Gly-extended G34. Additionally, these patents include methods for determining suitable treatments for patients suffering from gastrin hormone-mediated diseases or conditions.

Career Highlights

Throughout her career, Lorraine McLoughlin has worked with various companies, including Receptor Biologix, Inc. and Cancer Advances, Inc. Her expertise in immunoassays has positioned her as a valuable contributor to advancements in medical diagnostics.

Collaborations

Some of her notable coworkers include Stephen Grimes and John Little. Their collaborative efforts have likely enhanced the development and application of her innovative technologies.

Conclusion

Lorraine McLoughlin's contributions to gastrin hormone immunoassays exemplify her commitment to advancing medical diagnostics. Her patents reflect a significant step forward in the detection and treatment of gastrin hormone-related conditions.